메뉴 건너뛰기




Volumn 49, Issue 3, 2003, Pages 160-163

Interleukin-2 production by peripheral blood mononuclear cells from patients with myasthenia gravis

Author keywords

Interleukin 2; Myasthenia gravis; Peripheral blood mononuclear cells

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; INTERLEUKIN 2; PHYTOHEMAGGLUTININ;

EID: 0037234998     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069079     Document Type: Article
Times cited : (8)

References (18)
  • 1
    • 0015935638 scopus 로고
    • Autoimmune response to acetylcholine receptor
    • Patrick J, Lindstrom J: Autoimmune response to acetylcholine receptor. Science 1973;180:871-872.
    • (1973) Science , vol.180 , pp. 871-872
    • Patrick, J.1    Lindstrom, J.2
  • 2
    • 0023796692 scopus 로고
    • Regulation of antibody production by helper T cell clones in experimental autoimmune myasthenia gravis
    • Fujii Y, Lindstrom J: Regulation of antibody production by helper T cell clones in experimental autoimmune myasthenia gravis. J Immunol 1988;141:3361-3369.
    • (1988) J Immunol , vol.141 , pp. 3361-3369
    • Fujii, Y.1    Lindstrom, J.2
  • 3
    • 0030892692 scopus 로고    scopus 로고
    • Cytokines and the pathogenesis of myasthenia gravis
    • Zang G-X, Navikas V, Link H: Cytokines and the pathogenesis of myasthenia gravis. Muscle Nerve 1997;20:543-551.
    • (1997) Muscle Nerve , vol.20 , pp. 543-551
    • Zang, G.-X.1    Navikas, V.2    Link, H.3
  • 5
    • 0024674705 scopus 로고
    • High recombinant interleukin-2 sensitivity of peripheral blood lymphocytes from patients with myasthenia gravis: Correlations with clinical parameters
    • Cohen-Kaminsky S, Gaud C, Morel E, et al: High recombinant interleukin-2 sensitivity of peripheral blood lymphocytes from patients with myasthenia gravis: Correlations with clinical parameters. J Autoimmun 1989;2:241-258.
    • (1989) J Autoimmun , vol.2 , pp. 241-258
    • Cohen-Kaminsky, S.1    Gaud, C.2    Morel, E.3
  • 6
    • 0024429407 scopus 로고
    • Evidence of enhanced recombinant interleukin-2 sensitivity in thymic lymphocytes from patients with myasthenia gravis: Possible role in autoimmune pathogenesis
    • Cohen-Kaminsky S, Levasseur P, Binet JP, et al: Evidence of enhanced recombinant interleukin-2 sensitivity in thymic lymphocytes from patients with myasthenia gravis: Possible role in autoimmune pathogenesis. J Neuroimmunol 1989;24:75-85.
    • (1989) J Neuroimmunol , vol.24 , pp. 75-85
    • Cohen-Kaminsky, S.1    Levasseur, P.2    Binet, J.P.3
  • 7
    • 0032126158 scopus 로고    scopus 로고
    • Immunotherapy of experimental autoimmune myasthenia gravis: Selective effects of CTLA4Ig and synergistic combination with an IL2-diphtheria toxin fusion protein
    • McIntosh KR, Linsley PS, Bacha PA, et al: Immunotherapy of experimental autoimmune myasthenia gravis: Selective effects of CTLA4Ig and synergistic combination with an IL2-diphtheria toxin fusion protein. J Neuroimmunol 1998;87:136-146.
    • (1998) J Neuroimmunol , vol.87 , pp. 136-146
    • McIntosh, K.R.1    Linsley, P.S.2    Bacha, P.A.3
  • 8
    • 0024412228 scopus 로고
    • The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes
    • Tocci MJ, Matkovich DA, Collier KA, et al: The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol 1989;143:718-726.
    • (1989) J Immunol , vol.143 , pp. 718-726
    • Tocci, M.J.1    Matkovich, D.A.2    Collier, K.A.3
  • 9
    • 0001336181 scopus 로고    scopus 로고
    • A multicentered clinical open trial of FK506 (Tacrolimus) in steroid-resistant myasthenia gravis
    • Konishi T, Yoshiyama Y, Takamori M, et al: A multicentered clinical open trial of FK506 (Tacrolimus) in steroid-resistant myasthenia gravis. Ann Neurol 2000;48:487.
    • (2000) Ann Neurol , vol.48 , pp. 487
    • Konishi, T.1    Yoshiyama, Y.2    Takamori, M.3
  • 10
    • 0031081658 scopus 로고    scopus 로고
    • FK506 prevents induction of rat experimental autoimmune myasthenia gravis
    • Yoshikawa H, Isawa K, Satoh K, Takamori M: FK506 prevents induction of rat experimental autoimmune myasthenia gravis. J Autoimmun 1997;10:11-16.
    • (1997) J Autoimmun , vol.10 , pp. 11-16
    • Yoshikawa, H.1    Isawa, K.2    Satoh, K.3    Takamori, M.4
  • 11
    • 0344209838 scopus 로고    scopus 로고
    • Effects of FK506 on myasthenia gravis patients with high interleukin-2 productivity in peripheral blood mononuclear cells
    • in press
    • Utsugisawa K, Nagane Y, Yonezawa H, Obara D, Kondoh R, Tohgi H: Effects of FK506 on myasthenia gravis patients with high interleukin-2 productivity in peripheral blood mononuclear cells. Muscle Nerve 2002;in press.
    • (2002) Muscle Nerve
    • Utsugisawa, K.1    Nagane, Y.2    Yonezawa, H.3    Obara, D.4    Kondoh, R.5    Tohgi, H.6
  • 12
    • 0026494680 scopus 로고
    • Interleukin-2 production by peripheral blood mononuclear cells from patients with myasthenia gravis - Correlation with clinical severity
    • in Japanese
    • Utugisawa K, Sano M: Interleukin-2 production by peripheral blood mononuclear cells from patients with myasthenia gravis - Correlation with clinical severity. Clin Neurol 1992;32:474-478. [in Japanese].
    • (1992) Clin Neurol , vol.32 , pp. 474-478
    • Utugisawa, K.1    Sano, M.2
  • 13
    • 0027164486 scopus 로고
    • Production of interferon-γ and interleukin-2 by peripheral blood lymphocytes of patients with myasthenia gravis and other autoimmune diseases
    • Mokhtarian F, Shirazian D, Grob D: Production of interferon-γ and interleukin-2 by peripheral blood lymphocytes of patients with myasthenia gravis and other autoimmune diseases. Ann NY Acad Sci 1993;681:315-318.
    • (1993) Ann NY Acad Sci , vol.681 , pp. 315-318
    • Mokhtarian, F.1    Shirazian, D.2    Grob, D.3
  • 14
    • 0025992897 scopus 로고
    • Defective T lymphocyte function in nonthymectomized patients with myasthenia gravis
    • Ahlberg RE, Pirskanen R, Lefvert AK: Defective T lymphocyte function in nonthymectomized patients with myasthenia gravis. Clin Immunol Immunopathol 1991;60:93-105.
    • (1991) Clin Immunol Immunopathol , vol.60 , pp. 93-105
    • Ahlberg, R.E.1    Pirskanen, R.2    Lefvert, A.K.3
  • 15
    • 0030656375 scopus 로고    scopus 로고
    • Prognosis of myasthenia gravis: A retrospective study of 380 patients
    • Cosi V, Romani A, Lombardi M, et al: Prognosis of myasthenia gravis: A retrospective study of 380 patients. J Neurol 1997;244:548-555.
    • (1997) J Neurol , vol.244 , pp. 548-555
    • Cosi, V.1    Romani, A.2    Lombardi, M.3
  • 16
    • 0015152367 scopus 로고
    • Studies in myasthenia gravis: Review of a twenty-year experience in over 1200 patients
    • Osserman KE, Jenkins G: Studies in myasthenia gravis: Review of a twenty-year experience in over 1200 patients. Mt Sinai J Med 1971;38:497-536.
    • (1971) Mt Sinai J Med , vol.38 , pp. 497-536
    • Osserman, K.E.1    Jenkins, G.2
  • 17
    • 0025845202 scopus 로고
    • In situ production of interleukins in hyperplastic thymus from myasthenia gravis patients
    • Emilie D, Crevon MC, Cohen-Kaminsky S, et al: In situ production of interleukins in hyperplastic thymus from myasthenia gravis patients. Hum Pathol 1991;22:461-468.
    • (1991) Hum Pathol , vol.22 , pp. 461-468
    • Emilie, D.1    Crevon, M.C.2    Cohen-Kaminsky, S.3
  • 18
    • 0034028547 scopus 로고    scopus 로고
    • Marked increase in CD44-highly positive cells in hyperplastic thymuses from patients with myasthenia gravis
    • Utsugisawa K, Nagane Y, Tohgi H: Marked increase in CD44-highly positive cells in hyperplastic thymuses from patients with myasthenia gravis. Muscle Nerve 2000;23:507-513.
    • (2000) Muscle Nerve , vol.23 , pp. 507-513
    • Utsugisawa, K.1    Nagane, Y.2    Tohgi, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.